BJ

Bincy Jayaram

Active Director Director DIN 07995591
DIN 07995591 First appointment Feb 2018 Primary industry Business Services
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Feb 2018
Shareholding value •••• Premium profile

About Bincy Jayaram

Data last updated:

Bincy Jayaram is a Director at Sanfegan Biotech Private Limited (since 2018). The company operates in Business Services. Sanfegan Biotech Private Limited reported revenue of ₹4.90 Cr (FY 2024).

DIN 07995591
Primary Designation Director
Industry Business Services
First Appointment 22 Feb 2018
Oldest Company Age 8 yrs
Largest company Sanfegan Biotech Private Limited · ₹4.90 Cr (FY 2024)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Sanfegan Biotech Private Limited U74999KL2018PTC052096
Director22 Feb 20182018₹4.90 Cr (FY 2024)Active

Board colleagues of Bincy Jayaram

Directorship timeline

Open interactive timeline →
Sanfegan Biotech Private Limited
Premium access

Shareholding and investment profile for Bincy Jayaram

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Bincy Jayaram

Bincy Jayaram currently holds 1 directorship: Sanfegan Biotech Private Limited (Director, since 22 Feb 2018, revenue ₹4.90 Cr (FY 2024)).

Bincy Jayaram was first appointed on 22 Feb 2018 as Director at Sanfegan Biotech Private Limited.

The current boards of Bincy Jayaram's companies include Anu Thomas (Sanfegan Biotech Private Limited), Bobby Kurian (Sanfegan Biotech Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available